Rotavirus vaccine schedules may impact vaccine response among children in low- and middle-income countries (LMICs). Our objective was to review the literature evaluating the effects of monovalent (RV1) or pentavalent rotavirus vaccines schedules on vaccine response
In 2006, 2 rotavirus vaccines were licensed. We summarize the impact of rotavirus vaccination on hos...
OBJECTIVE: To evaluate the effect of a human-bovine reassortant pentavalent rotavirus vaccine (PRV) ...
Abstract Background The Rotavirus Efficacy and Safety Trial was a placebo-controlled Phase III study...
Rotavirus vaccine schedules may impact vaccine response among children in low- and middle-income cou...
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
BACKGROUND AND OBJECTIVES: Although both licensed rotavirus vaccines are safe and effective, it is o...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...
BackgroundRotavirus was the leading cause of acute gastroenteritis (AGE) in infants and young childr...
In 2006, 2 rotavirus vaccines were licensed. We summarize the impact of rotavirus vaccination on hos...
OBJECTIVE: To evaluate the effect of a human-bovine reassortant pentavalent rotavirus vaccine (PRV) ...
Abstract Background The Rotavirus Efficacy and Safety Trial was a placebo-controlled Phase III study...
Rotavirus vaccine schedules may impact vaccine response among children in low- and middle-income cou...
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
Background: Current oral rotavirus vaccines perform suboptimally in resource-poor settings. We inves...
BACKGROUND AND OBJECTIVES: Although both licensed rotavirus vaccines are safe and effective, it is o...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...
BackgroundRotavirus was the leading cause of acute gastroenteritis (AGE) in infants and young childr...
In 2006, 2 rotavirus vaccines were licensed. We summarize the impact of rotavirus vaccination on hos...
OBJECTIVE: To evaluate the effect of a human-bovine reassortant pentavalent rotavirus vaccine (PRV) ...
Abstract Background The Rotavirus Efficacy and Safety Trial was a placebo-controlled Phase III study...
DOI
Add to ORKG